These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21062201)

  • 1. Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.
    Lakey SL; Reed SD; LaCroix AZ; Grothaus L; Newton KM
    J Womens Health (Larchmt); 2010 Dec; 19(12):2175-81. PubMed ID: 21062201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of FDA-approved and compounded hormone therapy differs by specialty.
    Constantine GD; Archer DF; Graham S; Bernick BA; Mirkin S
    Menopause; 2016 Oct; 23(10):1075-82. PubMed ID: 27648594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider attributes associated with hormone therapy prescribing frequency.
    Spangler L; Reed SD; Nekhyludov L; Grothaus LC; LaCroix AZ; Newton KM
    Menopause; 2009; 16(4):810-16. PubMed ID: 19407679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey.
    Wang Y; Yang X; Li X; He X; Zhao Y
    Menopause; 2014 Nov; 21(11):1190-6. PubMed ID: 24736196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners.
    Menees SB; Patel DA; Dalton V
    J Womens Health (Larchmt); 2009 Aug; 18(8):1233-8. PubMed ID: 19630544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of multiple providers for regular care and women's receipt of hormone replacement therapy counseling.
    Gallagher TC; Geling O; Comite F
    Med Care; 2001 Oct; 39(10):1086-96. PubMed ID: 11567171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Cardiovascular Disease: An Assessment of Obstetrician-Gynecologists' Knowledge, Attitudes, and Practice Patterns.
    Jones KM; Carter MM; Schulkin J
    J Racial Ethn Health Disparities; 2015 Jun; 2(2):256-66. PubMed ID: 26863341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.
    Dubaut JP; Dong F; Tjaden BL; Grainger DA; Duong J; Tatpati LL
    J Womens Health (Larchmt); 2018 Jul; 27(7):859-866. PubMed ID: 29583064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female Pelvic Medicine and Reconstructive Surgery in Canada: A Survey of Obstetrician-Gynecologists and Urologists.
    Christakis MK; Shore EM; Pulver A; McDermott CD
    Female Pelvic Med Reconstr Surg; 2017; 23(3):195-203. PubMed ID: 27918338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists.
    Sobecki JN; Curlin FA; Rasinski KA; Lindau ST
    J Sex Med; 2012 May; 9(5):1285-94. PubMed ID: 22443146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.
    Power ML; Anderson BL; Schulkin J
    Menopause; 2009; 16(3):500-8. PubMed ID: 19169162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal Contraceptives for Endometrial Cancer Prevention in Obese and High-Risk Women in Virginia.
    Horst KE; Modesitt SC
    South Med J; 2016 Oct; 109(10):621-627. PubMed ID: 27706499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Health Record Adoption among Obstetrician/Gynecologists in the United States: Physician Practices and Satisfaction.
    Raglan GB; Margolis B; Paulus RA; Schulkin J
    J Healthc Qual; 2017; 39(3):144-152. PubMed ID: 28481842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy discontinuation: physician practices after the Women's Health Initiative.
    Newton KM; Reed SD; Grothaus LC; La Croix AZ; Nekhlyudov L; Ehrlich K; Ludman EJ
    Menopause; 2010 Jul; 17(4):734-40. PubMed ID: 20445466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.